Fenofibric Acid Capsule, Delayed Release
Product Images NDC 59651-217

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Fenofibric Acid (NDC 59651-217). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (45 mg (90 Capsules Bottle))

Fenofibric Acid Delayed-Release Capsules 45 mg label shows a red and yellow capsule with imprint 'CFB 45', NDC 59651-216-90, and bottle count of 90 capsules. The label states it is distributed by Aurobindo Pharma USA, Inc. and made in India, with storage instructions and a barcode.*

FDA Label Image

Package Label-principal Display Panel (135 mg (90 Capsules Bottle))

Label for Fenofibric Acid Delayed-Release Capsules 135 mg by Aurobindo Pharma Limited. The label states each delayed-release capsule contains choline fenofibrate equivalent to 135 mg fenofibric acid. It is for oral use, prescription only, and distributed by Aurobindo Pharma USA, Inc., with a package size of 90 capsules. Storage instructions and a barcode are also present.*

FDA Label Image

Chemical Structure (Fenofibric Str)

Chemical structure of fenofibric acid, the active ingredient in delayed-release fenofibric acid capsules by Aurobindo Pharma Limited.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.